Skip to content

Efficacy and safety of LED-LLLT for treatment of patients with seborrheic dermatitis: a multicenter, single-blind, randomized, clinical Trial

Efficacy and safety of LED-LLLT for treatment of patients with seborrheic dermatitis: a multicenter, single-blind, randomized, clinical Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088251
Enrollment
Unknown
Registered
2024-08-14
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

seborrheic dermatitis

Interventions

Experimental group:Low level light therapy with light-emitting diodes (LED-LLLT)
Control group:Desonide cream 0.05%

Sponsors

Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1: Patients with seborrheic dermatitis with a clinical severity score = 2. 2: Voluntary informed consent.

Exclusion criteria

Exclusion criteria: 1: Age 65 years old; 2: Pregnant and lactating women and those with recent pregnancy plans 3: Those with poor control of chronic diseases 4: Allergy to phototherapy or research drug ingredients; 5: Those who received any other form of seborrheic dermatitis treatment 2 weeks before the start of the study 6: Facial manifestations combined with other facial skin diseases (such as rose acne, acne, eczema, etc.) or other diseases (such as dermatomyositis, systemic lupus erythematosus) 7: Patients who are not expected to adhere to follow-up 8: Other conditions that the researcher believes cannot be included in the group

Design outcomes

Primary

MeasureTime frame
Disease-free duration;Overall improvement of clinical symptoms;

Secondary

MeasureTime frame
Seborrheic dermatitis area and severity index;Global assessment of clinical symptoms of seborrheic dermatitis;Skin Quality of Life Index;

Countries

China

Contacts

Public ContactBen Wang

Xiangya Hospital Central South University

wangben0804@163.com+86 138 7588 5737

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026